Unitedhealth Group Incorporated Stock EBITDA
| UNHH34 Stock | 52.46 0.02 0.04% |
UnitedHealth Group Incorporated fundamentals help investors to digest information that contributes to UnitedHealth Group's financial success or failures. It also enables traders to predict the movement of UnitedHealth Stock. The fundamental analysis module provides a way to measure UnitedHealth Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UnitedHealth Group stock.
UnitedHealth |
UnitedHealth Group Incorporated Company EBITDA Analysis
UnitedHealth Group's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current UnitedHealth Group EBITDA | 31.84 B |
Most of UnitedHealth Group's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UnitedHealth Group Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, UnitedHealth Group Incorporated reported earnings before interest,tax, depreciation and amortization of 31.84 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Healthcare Plans industry. The ebitda for all Brazil stocks is significantly lower than that of the firm.
UnitedHealth EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UnitedHealth Group's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UnitedHealth Group could also be used in its relative valuation, which is a method of valuing UnitedHealth Group by comparing valuation metrics of similar companies.UnitedHealth Group is rated below average in ebitda category among its peers.
UnitedHealth Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.7 T | |||
| Shares Outstanding | 65.4 B | |||
| Price To Book | 6.68 X | |||
| Price To Sales | 8.35 X | |||
| Revenue | 322.13 B | |||
| Gross Profit | 79.62 B | |||
| EBITDA | 31.84 B | |||
| Net Income | 20.12 B | |||
| Total Debt | 54.51 B | |||
| Book Value Per Share | 2.49 X | |||
| Cash Flow From Operations | 26.21 B | |||
| Earnings Per Share | 1.58 X | |||
| Price To Earnings To Growth | 1.64 X | |||
| Number Of Employees | 10 | |||
| Beta | 0.69 | |||
| Market Capitalization | 2.42 T | |||
| Total Asset | 245.71 B | |||
| Z Score | 27.4 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 245.71 B | |||
| Last Dividend Paid | 6.4 |
About UnitedHealth Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UnitedHealth Group Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UnitedHealth Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UnitedHealth Group Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in UnitedHealth Stock
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.